ViaDerma, Inc. engages with the manufacturing and sales of pharmaceutical related products. The company is headquartered in Las Vegas, Nevada. The company went IPO on 2008-06-10. The Company’s lead product is a topical antibiotic, which is focused on being sold under the brand name Vitastem. The firm also has products in development in the fields: anti-aging skin care, pain management, hair-loss, and toenail fungus. The products are based on a patent pending delivery system technology that allows for rapid mass transfer of the pharmaceutical active ingredient across the skin and into the body to provide immediate localized therapy. The firm utilizes a specific trade secret formulation system in the manufacture of all products. The Company’s products are sold to local medical practitioners and patients in clinics primarily in the Los Angeles, California area. The Company’s subsidiary is ViaDerma, II Inc.
Follow-Up Questions
Viaderma Inc (VDRM) 的本益比是多少？
Viaderma Inc 的本益比是 0.0924
Viaderma Inc 的 CEO 是誰？
Rui Sheng Liu 是 Viaderma Inc 的 President，自 2009 加入公司。
VDRM 股票的價格表現如何？
VDRM 的當前價格為 $0.0002，在上個交易日 decreased 了 0%。
Viaderma Inc 的主要業務主題或行業是什麼？
Viaderma Inc 屬於 Pharmaceuticals 行業，該板塊是 Health Care
